Birdwatch Note
2024-10-06 08:55:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
キューピーコーワゴールドαは第三種医薬品です。 https://hc.kowa.co.jp/otc/610 第三種医薬品は不調を起こす可能性が低い医薬品であることに留意が必要です。 https://mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000050568.pdf また、メーカーにて提供されている副作用も、 ・皮膚:発疹・発赤 ・かゆみ消化器:吐き気・嘔吐 であり、強い依存性、離脱症状については確認されていません。 https://www.kegg.jp/medicus-bin/japic_otc?japic_code=K1804000002 異常が発生した場合、個々人の体質に依存する可能性があるため、自分で判断するのではなく、まず医師の診断を受けることを推奨します。 医薬品副作用被害救済制度というものもあり、もし医薬品による被害を受けた場合の救済を受ける際にも、医師の診断が重要になります。 https://www.pmda.go.jp/kenkouhigai_camp/
Written by 0CA59D2AC383ACDA78BEDDA6AF16FCF65A38BABEBA71B8669044574045BF742D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1842107952758657492
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1842851078846730250
- noteId - 1842851078846730250
- participantId -
- noteAuthorParticipantId - 0CA59D2AC383ACDA78BEDDA6AF16FCF65A38BABEBA71B8669044574045BF742D Participant Details
- createdAtMillis - 1728204910371
- tweetId - 1842107952758657492
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- キューピーコーワゴールドαは第三種医薬品です。 https://hc.kowa.co.jp/otc/610 第三種医薬品は不調を起こす可能性が低い医薬品であることに留意が必要です。 https://mhlw.go.jp/file/05-Shingikai-11121000-Iyakushokuhinkyoku-Soumuka/0000050568.pdf また、メーカーにて提供されている副作用も、 ・皮膚:発疹・発赤 ・かゆみ消化器:吐き気・嘔吐 であり、強い依存性、離脱症状については確認されていません。 https://www.kegg.jp/medicus-bin/japic_otc?japic_code=K1804000002 異常が発生した場合、個々人の体質に依存する可能性があるため、自分で判断するのではなく、まず医師の診断を受けることを推奨します。 医薬品副作用被害救済制度というものもあり、もし医薬品による被害を受けた場合の救済を受ける際にも、医師の診断が重要になります。 https://www.pmda.go.jp/kenkouhigai_camp/
Note Ratings
rated at | rated by | |
2024-10-13 08:10:49 -0500 | Rating Details | |
2024-10-08 17:32:25 -0500 | Rating Details | |
2024-10-08 17:29:01 -0500 | Rating Details | |
2024-10-07 23:40:50 -0500 | Rating Details | |
2024-10-07 17:58:17 -0500 | Rating Details | |
2024-10-07 00:46:18 -0500 | Rating Details | |
2024-10-07 00:03:30 -0500 | Rating Details | |
2024-10-06 22:59:44 -0500 | Rating Details | |
2024-10-06 22:26:11 -0500 | Rating Details | |
2024-10-06 20:11:52 -0500 | Rating Details | |
2024-10-06 19:13:43 -0500 | Rating Details | |
2024-10-06 18:51:03 -0500 | Rating Details | |
2024-10-06 18:45:38 -0500 | Rating Details | |
2024-10-06 18:44:47 -0500 | Rating Details | |
2024-10-06 18:37:13 -0500 | Rating Details | |
2024-10-06 18:22:57 -0500 | Rating Details | |
2024-10-06 17:45:08 -0500 | Rating Details | |
2024-10-06 17:41:08 -0500 | Rating Details | |
2024-10-06 17:08:38 -0500 | Rating Details | |
2024-10-06 11:38:01 -0500 | Rating Details | |
2024-10-06 11:20:20 -0500 | Rating Details | |
2024-10-06 10:58:37 -0500 | Rating Details | |
2024-10-06 10:58:22 -0500 | Rating Details | |
2024-10-06 09:39:09 -0500 | Rating Details | |
2024-10-06 09:33:16 -0500 | Rating Details | |
2024-10-06 09:22:26 -0500 | Rating Details | |
2024-10-06 09:22:17 -0500 | Rating Details | |
2024-10-06 09:16:38 -0500 | Rating Details | |
2024-10-06 08:44:56 -0500 | Rating Details | |
2024-10-06 08:18:00 -0500 | Rating Details | |
2024-10-06 07:45:32 -0500 | Rating Details | |
2024-10-06 07:30:59 -0500 | Rating Details | |
2024-10-06 07:13:24 -0500 | Rating Details | |
2024-10-06 06:57:37 -0500 | Rating Details | |
2024-10-06 06:53:29 -0500 | Rating Details | |
2024-10-06 06:52:15 -0500 | Rating Details | |
2024-10-06 06:40:42 -0500 | Rating Details | |
2024-10-06 06:32:44 -0500 | Rating Details | |
2024-10-06 06:05:51 -0500 | Rating Details | |
2024-10-06 05:56:58 -0500 | Rating Details | |
2024-10-06 05:49:17 -0500 | Rating Details | |
2024-10-06 05:36:15 -0500 | Rating Details | |
2024-10-06 05:29:37 -0500 | Rating Details | |
2024-10-06 05:10:38 -0500 | Rating Details | |
2024-10-06 05:05:46 -0500 | Rating Details | |
2024-10-06 04:59:48 -0500 | Rating Details | |
2024-10-06 04:56:51 -0500 | Rating Details | |
2024-10-06 04:56:32 -0500 | Rating Details | |
2024-10-06 04:55:55 -0500 | Rating Details | |
2024-10-06 04:50:44 -0500 | Rating Details | |
2024-10-06 04:45:18 -0500 | Rating Details | |
2024-10-06 04:43:02 -0500 | Rating Details | |
2024-10-06 04:32:35 -0500 | Rating Details | |
2024-10-06 04:05:00 -0500 | Rating Details | |
2024-10-06 03:57:24 -0500 | Rating Details | |
2024-10-16 04:02:36 -0500 | Rating Details | |
2024-10-09 23:18:57 -0500 | Rating Details | |
2024-10-09 07:15:57 -0500 | Rating Details | |
2024-10-08 18:56:27 -0500 | Rating Details | |
2024-10-08 18:10:03 -0500 | Rating Details | |
2024-10-08 17:45:14 -0500 | Rating Details | |
2024-10-08 17:33:38 -0500 | Rating Details | |
2024-10-08 16:31:53 -0500 | Rating Details | |
2024-10-08 02:10:51 -0500 | Rating Details | |
2024-10-07 17:32:17 -0500 | Rating Details | |
2024-10-07 15:15:16 -0500 | Rating Details | |
2024-10-07 05:36:18 -0500 | Rating Details | |
2024-10-07 04:30:41 -0500 | Rating Details | |
2024-10-07 02:24:15 -0500 | Rating Details | |
2024-10-07 00:14:13 -0500 | Rating Details | |
2024-10-06 23:07:05 -0500 | Rating Details | |
2024-10-06 22:51:45 -0500 | Rating Details | |
2024-10-06 22:12:12 -0500 | Rating Details | |
2024-10-06 22:06:39 -0500 | Rating Details | |
2024-10-06 21:43:02 -0500 | Rating Details | |
2024-10-06 20:52:23 -0500 | Rating Details | |
2024-10-06 19:50:22 -0500 | Rating Details | |
2024-10-06 19:40:36 -0500 | Rating Details | |
2024-10-06 19:31:40 -0500 | Rating Details | |
2024-10-06 18:58:54 -0500 | Rating Details | |
2024-10-06 18:21:04 -0500 | Rating Details | |
2024-10-06 17:42:52 -0500 | Rating Details | |
2024-10-06 17:29:23 -0500 | Rating Details | |
2024-10-06 16:50:03 -0500 | Rating Details | |
2024-10-06 16:37:54 -0500 | Rating Details | |
2024-10-06 14:28:45 -0500 | Rating Details | |
2024-10-06 12:20:49 -0500 | Rating Details | |
2024-10-06 12:17:14 -0500 | Rating Details | |
2024-10-06 11:28:05 -0500 | Rating Details | |
2024-10-06 10:58:54 -0500 | Rating Details | |
2024-10-06 09:25:30 -0500 | Rating Details | |
2024-10-06 08:52:05 -0500 | Rating Details | |
2024-10-06 08:48:32 -0500 | Rating Details | |
2024-10-06 08:10:20 -0500 | Rating Details | |
2024-10-06 07:24:46 -0500 | Rating Details | |
2024-10-06 06:42:08 -0500 | Rating Details | |
2024-10-06 06:28:52 -0500 | Rating Details | |
2024-10-06 06:09:37 -0500 | Rating Details | |
2024-10-06 06:08:06 -0500 | Rating Details | |
2024-10-06 05:46:39 -0500 | Rating Details | |
2024-10-06 05:36:15 -0500 | Rating Details | |
2024-10-06 05:29:28 -0500 | Rating Details | |
2024-10-06 05:20:16 -0500 | Rating Details | |
2024-10-06 05:16:17 -0500 | Rating Details | |
2024-10-06 05:12:53 -0500 | Rating Details | |
2024-10-06 05:11:23 -0500 | Rating Details | |
2024-10-06 05:06:40 -0500 | Rating Details | |
2024-10-06 05:03:06 -0500 | Rating Details | |
2024-10-06 05:00:50 -0500 | Rating Details | |
2024-10-06 04:57:25 -0500 | Rating Details | |
2024-10-06 04:53:22 -0500 | Rating Details | |
2024-10-06 04:37:59 -0500 | Rating Details | |
2024-10-06 04:37:12 -0500 | Rating Details | |
2024-10-06 04:37:01 -0500 | Rating Details | |
2024-10-06 04:27:14 -0500 | Rating Details | |
2024-10-06 04:12:53 -0500 | Rating Details | |
2024-10-06 03:55:48 -0500 | Rating Details |